Makale
Tam Makale
Uluslararası
2022
Açık erişimli
May endocan be a new biomarker in the diagnosis of endometriosis?
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION
Cilt 51 · Sayı 7 · 01.09.2022
Özet
Aim: As known, inflammatory substances are considered to have a role in the onset and progression of endometriosis. In this study, we aimed to find a biomarker that can be used in the diagnosis of endometriosis by investigating the serum levels of endocan, which is a substance that we know to have an important role in angiogenesis and inflammation, in patients with endometriosis.
Anahtar kelimeler
PATHOGENESIS
PAIN
Serum
Biomarker
PATHOPHYSIOLOGY
Endometriosis
Endocan
Atıf için künye
Cimilli Şenocak, G. N., Yapça, Ö. E., Topdağı Yılmaz, E. P., Öztürk, N., Ozdes, S., & Kumtepe, Y. (2022). May endocan be a new biomarker in the diagnosis of endometriosis? JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 51(7). https://doi.org/10.1016/j.jogoh.2022.102423
BibTeX
@article{cimillisenocak2022-235519,
author = {Cimilli Şenocak, Gamze Nur and Yapça, Ömer Erkan and Topdağı Yılmaz, Emsal Pınar and Öztürk, Nurinnisa and Ozdes, Sevda and Kumtepe, Yakup},
title = {May endocan be a new biomarker in the diagnosis of endometriosis?},
journal = {JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION},
year = {2022},
volume = {51},
number = {7},
issn = {2468-7847},
doi = {10.1016/j.jogoh.2022.102423},
url = {https://akademik.atauni.edu.tr/yayinlar/235519-may-endocan-be-a-new-biomarker-in-the-diagnosis-of-endometriosis}
}